Ruchi V. Shah

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Ruchi

Last Name

Shah

NPI

1770110942

Faculty ID

19491

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

203560

Is Open Scheduling

On

Natalie Buslach

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Natalie

Last Name

Buslach

NPI

1730709155

Faculty ID

18359

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

202071

Is Open Scheduling

On

Michele J. Buonora

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Michele

Last Name

Buonora

NPI

1205331543

Faculty ID

17891

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

76629

Is Open Scheduling

On

Matthew C. Holm

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Matthew

Last Name

Holm

NPI

1114488715

Faculty ID

17431

CMO Specialties

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

111591

Is Open Scheduling

Off

Kristine E. Torres-Lockhart

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/0b28f080-c3c8-11eb-9ea2-7374238588d1.jpg

First Name

Kristine

Last Name

Torres-Lockhart

NPI

1023467115

Faculty ID

16568

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Kristine Torres-Lockhart, MD, FASAM is an Assistant Professor of Medicine in the Division of General Internal Medicine and Department of Psychiatry and Behavioral Sciences at Montefiore Medical Center and the Albert Einstein College of Medicine, as well as the founding director of the Addiction Consult Service at Montefiore's Weiler Hospital. She is Program Director of the Addiction Medicine Fellowship and Co-Director of the Addiction Medicine rotation for medical trainees. An addiction medicine and internal medicine physician, she leads the development and implementation of health system interventions to improve substance use disorder (SUD) care in acute care settings and transitions of care to post-acute and ambulatory care settings.</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><br />Dr. Torres-Lockhart provides SUD treatment, HIV/AIDS care, hepatitis C treatment, and general internal medicine care at several sites across Montefiore Medical Center, including a community health care center. She also actively teaches and supervises medical students, residents, and fellows. She is double board certified in addiction medicine and internal medicine and credentialed as an HIV specialist by the American Academy of HIV Medicine.&nbsp;<br /><br />Dr. Torres-Lockhart completed her fellowship training in addiction medicine at Montefiore Medical Center. Prior to arriving at Montefiore, she completed her residency training in internal medicine and primary care at Brigham and Women&rsquo;s Hospital in Boston, MA, where she also served as primary care chief medicine resident at the West Roxbury and Jamaica Plain Veterans Affairs Medical Centers. She received her undergraduate degree from Dartmouth College and her medical degree from the Geisel School of Medicine at Dartmouth. She is the PI for a HRSA training grant and co-PI for an OASAS training grant to lead the development of educational opportunities in building the addiction medicine workforce. She currently serves on the Board of Directors for the New York Society of Addiction Medicine previously as Communication Chair and now as Secretary.&nbsp;</p>

Research Areas

Research Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Singh-Tan, S., <strong>Torres-Lockhart, K.</strong>, Jakubowski, A., Lu, T., Starrels, J., De Lima, P., Arnsten, J., Nahvi, S., Southern, W. (2023). Addiction Consult Service and Inpatient Outcomes Among Patients with Alcohol Use Disorder. &nbsp;/J Gen Intern Med/, 1-8. doi:10.1007/s11606-023-08202-7</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Jakukowski, A., Singh-Tan, S., <strong>Torres-Lockhart, K</strong>., Nahvi, S., Stein, M., Fox, A. D., &amp; Lu, T. (2023). Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. /Addict Sci Clin Pract, 18/(1), 31. doi:10.1186/s13722-023-00386-x</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Calcaterra, S. L., Bottner, R., Martin, M., Englander, H., Weinstein, Z. M., Weimer, M. B., Lambert, E., Ronan, M., Huerta, S., Zaman, T., Ullal, M., Peterkin, A., <strong>Torres-Lockhart, K.</strong>, Buresh, M., O&rsquo;Brien, M., Synder, H., Herzig, S. J. (2022). Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines. /J Hosp Med, 17(9),/679-692/./doi:10.1002/jhm.12908</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><strong>Torres-Lockhart, K.</strong> E., Lu, T. Y., Weimer, M. B., Stein, M. R., &amp; Cunningham, C. O. (2022). Clinical Management of Opioid Withdrawal. /Addiction, 117/(9), 2540-2550. doi:10.1111/add.15818</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Cunningham, C. O., Khalid, L., Deng, Y., <strong>Torres-Lockhart, K.</strong>, Masyukova, M., Thomas, S., Zhang, C., Lu, T. (2022). A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic. /J Subst Abuse Treat, 135/, 108641. doi:10.1016/j.jsat.2021.108641</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Joseph, G., <strong>Torres-Lockhart, K.</strong>, Stein, M. R., Mund, P. A., &amp; Nahvi, S. (2021). Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19. /J Subst Abuse Treat, 122/, 108219. doi:10.1016/j.jsat.2020.108219</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">He, L., <strong>Torres-Lockhart, K.</strong>, Forster, N., Ramakrishnan, S., Greninger, P., Garnett, M. J., McDermott, U., Rothenberg, S.M., Benes, C.H., Ellisen, L. W. (2013). Mcl-1 and FBW7 control a dominant survival pathway underlying HDAC and Bcl-2 inhibitor synergy in squamous cell carcinoma. /Cancer Discov, 3/(3), 324-337. doi:10.1158/2159-8290.CD-12-0417</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">Ibrahim, Y. H., Garcia-Garcia, C., Serra, V., He, L., <strong>Torres-Lockhart, K</strong>., Prat, A., Anton, P., Cozar, P., Guzman, M., Grueso, J., Rodriguez, O., Calvo, M.T., Aura, C., Diez, O., Rubio, I.T., Perez, J., Rodon, J., Cortes, J., Ellisen, L.W., Scaltriti, M., Baselga, J. (2012). PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition. /Cancer Discov, 2/(11), 1036-1047. doi:10.1158/2159-8290.CD-11-0348</p>

EMR ID

113089

Biography

<p>Kristine E. Torres-Lockhart, MD, FASAM, is Director, Addiction Medicine Fellowship Program at Montefiore Einstein, Founding Director, Addiction Consult Service at Weiler Hospital and Assistant Professor, General Internal Medicine and Psychiatry and Behavioral Sciences at our Albert Einstein College of Medicine. Dr. Torres-Lockhart is a general internist, primary care provider and addiction medicine specialist. She focuses on caring for people who use substances and people with substance use disorders, providing care in hospital settings and in outpatient clinics.</p><p>After obtaining her Bachelor of Arts in neuroscience from Dartmouth College in 2010, Dr. Torres-Lockhart earned her Doctor of Medicine at the Geisel School of Medicine at Dartmouth in 2016. She completed an internship and residency in internal medicine and primary care at Brigham and Women&rsquo;s Hospital in 2019. Following this, Dr. Torres-Lockhart completed a fellowship in addiction medicine at Montefiore Einstein in 2020.</p><p>Dr. Torres-Lockhart's research focuses on evidence-based and harm-reduction-oriented strategies for addressing substance use disorder care in acute care settings, integration of addiction medicine into medical education and optimizing transitions of care for people who use drugs. She has been principal investigator and co-investigator on funded research projects and her work has been published in numerous peer-reviewed publications. Dr. Torres-Lockhart has also shared her work through numerous invited presentations, abstracts and poster presentations. She is a reviewer for scientific journals, including Addiction Science and Clinical Practice, the Journal of Addiction Medicine, the Journal of Substance Abuse Treatment and the Journal of Hospital Medicine.</p><p>Dr. Torres-Lockhart is board certified by the American Board of Internal Medicine and the American Board of Preventive Medicine with certification in Addiction Medicine. She is a Fellow of the American Society of Addiction Medicine, board member of the New York Society of Addiction Medicine and member of the Association for Multidisciplinary Education and Research in Substance Use and Addiction. In 2022, Dr. Torres-Lockhart received the President&rsquo;s Award at the New York Society of Addiction Medicine&rsquo;s Annual Conference. In 2023, she received the Quality Improvement Champion honor at the United Hospital Fund's Tribute to Excellence in Health Care and was a Rising Star Nominee for the Department of Medicine&rsquo;s Physician Recognition Awards at Montefiore Einstein.</p>

Is Open Scheduling

Off

Peter L. Tenore

https://assets.montefioreeinstein.org/profiles/images/9816-tenore.jpg

First Name

Peter

Last Name

Tenore

NPI

1316063027

Faculty ID

9816

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

Dr. Tenore is a Medical Director in the Division of Substance Abuse and is a wekk known figure in this field, having published in several journals and providing education in substance abuse to local and state agencies. He is an advisor to the New York State Ofice of Alcoholism and Substance Abuse Services and the federal Center for Substance Abuse Treatment. He is certified in Internal Medicine and by examination in Addiction Medicine and a New York State HIV Provider. His particular interests are management of cocaine and other addictions as well as providing hepatitis C and HIV treatment in the methadone clinic setting.

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

DINO-VAMP: A Helpful Acronym in Determining Optimal Methadone Dosing and Brief review of Dosing Literature, Journal of Maintenance in the Addictions, Vol.2(4).

Guidance On Optimal Methadone Dosing, Addiction Treatment Forum, Vol.12 (2).

Methadone:A Medical Model in "Innovations in Substance Abuse Treatment and Policy," Yale University Center for Interdisciplinary Research, Yale Publicatinos, New Haven, CT.

Three Oral Formulations of Methadone: A Clinical and Pharmacodynamic Comparison, Journal of Substance Abuse Treatment, Vol. 17(3), Gourevitch, Hartell, Tenore, et al.

EMR ID

3901

Is Open Scheduling

Off

Melissa R. Stein

https://assets.montefioreeinstein.org/profiles/images/physphoto/Stein_Melissa_MD_LC_2013_06-18.jpg

First Name

Melissa

Last Name

Stein

NPI

1699865592

Faculty ID

9444

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><strong>Current Investigations</strong></p>

<ol start="1" style=" margin-bottom: 0in;" type="1">
<li>Development of an Objective Structured Clinical Examination (OSCE) in Substance Abuse</li>
</ol>

<p>&#160;</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4263

Is Open Scheduling

Off

Joanna L. Starrels

https://assets.montefioreeinstein.org/profiles/images/physphoto/Starrels_Joanna_L_MD_11117176.jpg

First Name

Joanna

Last Name

Starrels

NPI

1124031729

Faculty ID

11404

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>&nbsp;</p>
<p><span style="font-size: medium;"><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 11pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">Dr. Starrels is Professor of Medicine (with tenure) at Albert Einstein College of Medicine and Montefiore Medical Center, Associate Chief of Research in the <a title="Division of General Internal Medicine" href="http://www.einstein.yu.edu/faculty/medicine/generalinternalmedicine"><s… style="color: #3b5b98; text-decoration: none; text-underline: none;">Division of General Internal Medicine</span></a>, and Director of the IMPOWR-ME Research Center. She is board-certified in Internal Medicine and Addiction Medicine.&nbsp;Dr. Starrels is nationally recognized for her expertise in research, clinical care, education, and health policy to address the opioid crisis. Her research focuses on&nbsp;opioid management for patients with chronic pain with or without opioid use disorder. In particular, she studies the benefits and harms of opioid tapering, treatment agreements,&nbsp;urine drug testing,&nbsp;prescription monitoring programs, and medical cannabis use. She also studies the impact of opioid use&nbsp;on HIV outcomes, collaborative care models for integrating behavioral health care and pain management, treatment of opioid use disorder in primary care, and integrated treatment for opioid use disorder and chronic pain.&nbsp;Her work has been funded by&nbsp;grants from&nbsp;the National Institute on Drug Abuse (NIDA), the Society of General Internal Medicine,&nbsp;the New York Community Trust, and the Einstein-Montefiore Center for AIDS Research. Her expertise has been recognized </span><span style="color: black; line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 11pt; mso-fareast-font-family: Calibri; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-fareast-theme-font: minor-latin;">by invitations to serve as</span><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 11pt; mso-fareast-font-family: Calibri; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-fareast-theme-font: minor-latin;"> expert consultant to the New York City Department of Health and Mental Hygiene, the New York State Department of Health, and the Centers for Disease Control and Prevention (CDC) for developing guidelines and initiatives to improve opioid prescribing.</span></span></p>
<p><span style="font-size: medium;"><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 11pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">Dr. Starrels joined the Einstein/Montefiore faculty in 2008. Her teaching and clinical care activities also focus on chronic pain and substance use. She is faculty in the Center on Comparative Effectiveness Research, leads a number of opioid and pain related initiatives, is teaching faculty in the Internal Medicine and Primary Care and Social Internal Medicine residency training programs, and is attending physician at the Montefiore Family Care Center where she focuses on caring for patients with chronic pain and who use opioids and/or medical cannabis.</span></span></p>
<p><span style="font-size: medium;"><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 11pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 11pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">Before joining Einstein/Montefiore, Dr. Starrels received her BA from Wesleyan University, where she majored in the Science in Society Program, and her MD from Jefferson Medical College. She completed her residency in Internal Medicine at Columbia University Medical Center and fellowship in the Robert Wood Johnson Foundation Clinical Scholars Program at the University of Pennsylvania, where she received a MS in Health Policy Research. </span></span></span></p>
<p>&nbsp;</p>

Research Areas

Expert Tags

Expert Summary

<p class="MsoNormal" style="line-height: 15.6pt;">Dr. Starrels is a physician, teacher and researcher who focuses on the safety and effectiveness of opioids for the management of chronic pain. Her research centers on&nbsp;defining best practices for&nbsp;managing chronic pain in&nbsp;primary care and HIV-treatment settings.&nbsp;She studies the benefits and harms of using treatment agreements,&nbsp;urine drug testing,&nbsp;and prescription monitoring programs in pain management; the effectiveness of&nbsp;collaborative care models for integrating behavioral health care and pain management; treatment of opioid use disorders in primary care settings; and the impact of opioid analgesic use,&nbsp;misuse and disorders&nbsp;on HIV outcomes.&nbsp;</p>
<p><span style="line-height: 15.6pt;">Her work has been funded by&nbsp;grants from&nbsp;the National Institute on Drug Abuse (NIDA), the Society of General Internal Medicine,&nbsp;the New York Community Trust, and the Einstein-Montefiore Center for AIDS Research. Dr. Starrels also works to improve policies and guidelines to improve the safety of opioid prescribing. She serves as consultant to the New York City Department of Health and Mental Hygiene on several initiatives to reduce prescription drug abuse, addiction and overdose in New York City. She was a field reviewer for the Federation of State Medical Board&rsquo;s 2013 Model Policy on the Use of Opioid Analgesics for the Treatment of Chronic Pain, and served as a core expert for the Centers for Disease Control and Prevention (CDC) 2016 opioid prescribing guidelines. She is board-certified in both Internal Medicine and Addiction Medicine.&nbsp;</span></p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Adult Medicine<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

Selected Publications

<ol>
<li><strong><strong>Starrels JL</strong>, </strong>Becker WC, Alford DP, Kapoor, A, Williams AR, Turner BJ. Treatment Agreements and Urine Drug Testing to Reduce Opioid Misuse in Patients with Chronic Pain: A Systematic Review. Annals of Internal Medicine.2010;152:712-720.</li>
<li><strong>Starrels JL</strong>, Becker WC, Weiner MG, Li X, Heo M, Turner, BJ. Low Use of Opioid Risk Reduction Strategies for Even High Risk Primary Care Patients with Chronic Pain. Journal of General Internal Medicine. 2011;26(9);958-64.</li>
<li><strong>Starrels JL</strong>, Fox AD, Kunins HV, Cunningham CO. They Don&rsquo;t Know What They Don&rsquo;t Know: Internal Medicine Residents&rsquo; Knowledge and Confidence in Urine Drug Test Interpretation for Patients with Chronic Pain. Journal of General Internal Medicine. 2012;27(11):1521-1527.</li>
<li>Bachhuber MA, Hennesy S, Cunningham CO, <strong>Starrels JL</strong>. Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013. American Journal of Public Health. 2016;106(4):686-8.&nbsp;</li>
<li><strong>Starrels JL</strong>, Peyser D, Haughton L, Fox AD, Merlin J, Arnsten JH, Cunningham CO. When HIV treatment goals conflict with guideline-based opioid prescribing: A qualitative study of HIV treatment providers. Substance Abuse. 2016;37(1):148-53.</li>
<li>Buonora M, Perez H, Heo M, Ning Y, Cunningham CO, <strong>Starrels JL</strong>. Race and gender are associated with opioid dose reduction among patients receiving chronic opioid therapy. Pain Medicine. 2018.&nbsp;</li>
</ol>

EMR ID

5145

Is Open Scheduling

Off

Deepika E. Slawek

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/1fa12a40-ee0f-11ee-904c-09056fc0ef1f.jpg

First Name

Deepika

Last Name

Slawek

NPI

1588920508

Faculty ID

16173

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal" style="font-size: 16px; margin: 0in; font-family: Aptos, sans-serif; caret-color: #212121; color: #212121;">Deepika Slawek, MD, MPH, MS is an Associate Professor of Medicine at Montefiore Health Systems and Albert Einstein College of Medicine in Bronx, NY in the Division of General Internal Medicine. She is board certified in Infectious Diseases, Addiction Medicine, and Internal Medicine and is the Co-Director of the Montefiore Medical Cannabis Program. Dr. Slawek &nbsp;studies how to reduce morbidity and mortality in people with HIV (PWH) and people who use drugs (PWUD) using a harm reduction framework. She aims to study solutions for PWH and PWUD informed by her clinical experiences and patient&rsquo;s experiences. Dr. Slawek is the recipient of a K23 award from the National Institute on Drug Abuse to test how different formulations of medical cannabis effect neuropathic pain and inflammation in PLWH in an innovative quasi-experimental study. She is leading groundbreaking foundation-funded research to determine whether medical cannabis is effective in reducing opioid analgesic use in people with pain.</p>
<p class="MsoNormal" style="font-size: 16px; margin: 0in; font-family: Aptos, sans-serif; caret-color: #212121; color: #212121;">&nbsp;</p>
<p class="MsoNormal" style="font-size: 16px; margin: 0in; font-family: Aptos, sans-serif; caret-color: #212121; color: #212121;">Prior to joining Montefiore-Einstein, Dr. Slawek completed her residency training in Primary Care Internal Medicine at Stony Brook University Hospital and her Infectious Diseases Fellowship at New York University/Bellevue Hospital Center. She holds a Masters of Science in Clinical Research Methods from Albert Einstein College of Medicine.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Adult Medicine<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

Selected Publications

<p class="MsoNormal" style="margin: 0in; font-size: 11pt; font-family: Arial, sans-serif; caret-color: #000000; color: #000000; font-style: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; text-decoration: none; background-color: white;"><a name="_GoBack"></a>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Slawek DE</strong>, Arnsten J, Zhang C, Grossberg R, Stein M, Cunningham CO. Daily and near-daily cannabis use is associated with HIV viral load suppression in people living with HIV who use cocaine.&nbsp;AIDS Care.&nbsp;Vol 32, 2020.&nbsp;Doi:&nbsp;<a title="https://doi.org/10.1080/09540121.2020.1799922&quot; href="https://doi.org/10.1080/09540121.2020.1799922">10.1080/09540121.2020.17… />2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Slawek DE</strong>, Merlin JS, Owens MA, Long DM, Gonzalez CE, White DM, Lopez SA, Heath SL, Goodin BR. Increasing age is associated with elevated circulating interleukin-6 and enhanced temporal summation of mechanical pain in people living with HIV and chronic pain.&nbsp;Pain Reports. 2020; 5(6):p e859.&nbsp;doi: 10.1097/PR9.0000000000000859<br />3. &nbsp; &nbsp;&nbsp;<strong>Slawek DE</strong>, Althouse AD, Feldman RF, &hellip; Merlin JS. Cannabis dispensary staff approaches to counseling on potential contraindications to cannabis use: Insights from a national self-report survey.&nbsp;BMC Primary Care. 2023 Jul 14;24(1):145. PMID: 37442944, PMCID: PMC10347704.<br /><!-- [if !supportLists]-->4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<!--[endif]-->Ross J,&nbsp;<strong>Slawek DE</strong>, Yamada J, Starrels J, Arnsten JH. Increasing access to medical cannabis: establishment of a medical cannabis program in a safety-net academic medical center.&nbsp;NEJM Catalyst. 2022 January; 3(2):CAT.21.0373.doi:10.1056/CAT.21.0373&nbsp;<br />5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<!--[endif]-->Zolotov Y, Lomba J, Ghiroli M, Masyukova M, Arnsten JH, Starrels JL, Ross J, Cunningham CO,&nbsp;<strong>Slawek DE</strong>. &ldquo;It doesn&rsquo;t make any sense to even try&rdquo;: the disruptive impact of COVID-19&rsquo;s first wave on people with chronic pain using medical cannabis in New York.&nbsp;Journal of Cannabis Research. 2023 March 29;5(1):10.&nbsp;doi: 10.1186/s42238-023-00180-1. PubMed PMID: 36978185; PubMed Central PMCID: PMC10049907.<br />6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<!--[endif]--><strong>Slawek DE</strong>, Arnsten JH (2023). Medical use of cannabis and cannabinoids in adults.&nbsp;UpToDate. 2023 Jul 31.&nbsp;<a href="https://www.uptodate.com/contents/medical-use-of-cannabis-and-cannabino…;

EMR ID

6361

Biography

<p>Deepika E. Slawek, MD, MS, MPH, is an attending physician at Montefiore Einstein and Assistant Professor, Medicine at our Albert Einstein College of Medicine. Her clinical expertise lies in HIV care and addiction treatment. She provides primary care for HIV patients and management of subsequent chronic conditions, as well as consulting on the management of substance use disorders.</p><p>After completing her Bachelor of Science in human biology at the University of Texas at Austin in 2006, Dr. Slawek earned her Master of Public Health at George Washington University in 2008. She earned her Doctor of Medicine at Texas A&M School of Medicine in 2012, then pursued postdoctoral training in internal medicine at the State University of New York at Stony Brook, completing an internship in 2013 and her internal medicine residency in 2015. She completed a fellowship in infectious diseases at New York University in 2017 before coming to Montefiore Einstein, where she pursued a fellowship in general internal medicine and a Master of Science in Clinical Research Methods, completing both in 2019.</p><p>Building on her clinical expertise, Dr. Slawek&rsquo;s research focuses on improving outcomes in people living with HIV (PLWH). She is currently studying how medical cannabis affects pain in PLWH and is receiving funding from the National Institute on Drug Abuse. She has been principal investigator on a number of funded research projects, and she has given national and international presentations. Dr. Slawek&rsquo;s work has been published in numerous peer-reviewed journals, book chapters and review articles, and she is a reviewer for scientific journals including <em>Annals of Internal Medicine</em>, the <em>Journal of General Internal Medicine</em>, <em>AIDS and Behaviour</em> and <em>AIDS Care</em>, among others.</p><p>Dr. Slawek is board certified in Internal Medicine, Infectious Diseases and Addiction Medicine. She is a member of the Society for General Internal Medicine, the American Society for Addiction Medicine and The Association for Multidisciplinary Education and Research in Substance use and Addiction.</p>

Is Open Scheduling

On

Serena L. Roth

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/2b503920-c3ca-11eb-9ea2-7374238588d1.jpg

First Name

Serena

Last Name

Roth

NPI

1689877920

Faculty ID

12805

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Serena Roth is a general internist with a special interest in the management of patients with chronic pain. She completed a medical degree at NYU School of Medicine and a Primary Care/Internal Medicine residency at the University of Pennsylvania. Following residency, she conducted tuberculosis research in Bangkok, Thailand at the Centers for Disease Control and Prevention (CDC).&nbsp;<br /><br />Dr. Roth joined the Montefiore Einstein Division of General Internal Medicine in 2011 as a clinician educator. She is active in medical student and resident education, especially regarding chronic pain and opioids. She was a site director for the Ambulatory and Internal Medicine clerkships from 2014-2018 and is now an Associate Program Director for the Internal Medicine Residency Program.&nbsp;</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Adult Medicine

Elsevier Profile

Selected Publications

<p>Guideline adherence and reasons for recommending dose reduction in a primary care-based opioid management clinic. Khalid L, Roth S, Zhang C, Burkenroad A, Carrozzi G, Starrels J. J Opioid Manag. Nov-Dec 2021;17(6):481-488. doi: 10.5055/jom.2021.0682.</p>
<p>New normal: caring for hospitalised patients in the Bronx, New York, during COVID-19. Akiyama M, Arnsten J, Roth S. Intern Med J. 2021 Feb;51(2):288-290. doi: 10.1111/imj.15040.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22817684&quot; target="_blank" rel="noopener">Concurrent influenza virus infection and tuberculosis in patients hospitalized with respiratory illness in Thailand.</a> Roth S, Whitehead S, Thamthitiwat S, Chittaganpitch M, Maloney SA, Baggett HC, Olsen SJ. Influenza Other Respi Viruses. 2012 Jul 21. doi: 10.1111/j.1750-2659.2012.00413.x.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?linkname=pubmed_pubmed&amp;from_uid=…; target="_blank" rel="noopener">Unintended consequences of a quality measure for acute bronchitis.</a> Roth S, Gonzales R, Harding-Anderer T, Bloom FJ Jr, Graf T, Stahl MS, Maselli JH, Metlay JP.<span class="jrnl" title="The American journal of managed care"> Am J Manag Care</span>. 2012 Jun 1;18(6):e217-24.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/18551887&quot; target="_blank" rel="noopener">Music therapy: a novel motivational approach for dually diagnosed patients.</a> Ross S, Cidambi I, Dermatis H, Weinstein J, Ziedonis D, Roth S, Galanter M. J Addict Dis. 2008;27(1):41-53.</p>

EMR ID

5522

Is Open Scheduling

On